doi: 10.1210/clinem/dgaa285 98 TalmorADunphyB
A 2025 study found that tripling semaglutides dose to 7.2 mg led to roughly 19% weight loss over 72 weeks, compared to 16% at the standard dose, a meaningful gain, though with higher rates of side effects
Ma LY, Liu SF, Ma ZQ, Guo YG, Li M, Gao Y, Wen YT, Niu Y, Sui HX, Li BS, Li Y, Lv YL, Huang Y, Zhai JJ (2025) Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating -secretase and -secretase and alleviating oxidative stress in HT-22 cells
Check Out Our 5 Star Reviews Additional Services We Offer Infusion Therapy Injection Treatments Intravenous Immunoglobulin Therapy Medical Conditions Asthma Crohns Disease Fibromyalgia Gout Inflammatory Eye Disease Inflammatory Skin Disease Iron Deficiency Lupus Multiple Sclerosis Myositis Osteoporosis Rheumatoid Arthritis Ulcerative Colitis Vasculitis IVIG Infusions Platelet-Rich Plasma (PRP)
J.FiskumG